论文信息 - Initial testing (stage 1) of tazemetostat (EPZ‐6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program - 字舞流文

Initial testing (stage 1) of tazemetostat (EPZ‐6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program

P. Houghton | Katherine Cosmopoulos | Malcolm A. Smith | Dias Kurmashev | R. Kurmasheva | C. Klaus | H. Keilhack | M. Sammons | Edward Favours | Jianwrong Wu